Endometrial Thinning after Ovarian Stimulation using Letrozole or Clomiphene Citrate: A Randomized Trial
Keywords:
Clomiphene citrate; letrozole; ovulation induction; endometrial thickness; consecutive cyclesAbstract
Objective: To compare endometrial thickness after three consecutive cycles of ovulation induction with clomiphene
citrate versus letrozole.
Methods: Eighty-four women with normal menstrual interval who attended the university infertility clinic from
June 2016 to March 2017 were eligible for the study. After the endometrial thickness of baseline cycle was recorded,
all participants were randomized into two groups of clomiphene citrate or letrozole treatment for three consecutive
cycles. Endometrial thickness and estradiol level were measured when at least one follicle reached 17 mm in diameter.
The differences in endometrial thickness relative to baseline of the two groups were compared.
Results: A total of 62 patients completed three cycles of ovarian stimulation. Both drugs resulted in significantly
thinner endometrium compared with the baseline cycle thickness. The mean endometrial thickness was significantly
decreased in the clomiphene citrate group compared with letrozole group (7.46 ± 1.71 vs 8.88 ± 2.34 mm, p = 0.029).
Estradiol level on the day of induced ovulation was significantly higher in the clomiphene citrate group than in
the letrozole group (706.0 (207.9, 2209.0) vs 168.7 (30.0, 401.8), p < 0.001). The number of the follicles reaching 17 mm
on the day of induced ovulation was higher in the clomiphene citrate group (1.9 ± 0.8 vs 1.4 ± 0.5, p = 0.002).
Conclusion: Letrozole had less effect on endometrium thinning after three consecutive cycles of induced ovulation
compared with clomiphene citrate.
Downloads
Published
How to Cite
Issue
Section
License
Users are free to share, copy, and redistribute all articles published in the Siriraj Medical Journal (SMJ) in any medium or format as long as you follow the following terms:
- Attribution — You must give appropriate credit, provide a link to the material, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the publisher endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
- NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.